Health Policy – Talk Bio

Federal Judge Blocks NIH Grant Caps as HHS Appeals Ruling

2 weeks ago talkbio0Tagged Administration occupational activities, Administrative Procedure Act, appeal, CHARGE Syndrome, federal judge, Health Policy, Indirect, injunction, Legal, Medical Research activity, NIH Mouse, Permanent, research, Transplant Registry Unified Management Program, U.S., United States

NIH, HHS, research funding, grant caps, indirect costs, federal judge, permanent injunction, Trump administration, medical research, Administrative Procedure Act, legal appeal, U.S. healthcare policy.

Robert F. Kennedy Jr. Confirmed as HHS Secretary in Close Senate Vote

2 months ago talkbio0Tagged Administration occupational activities, CHARGE Syndrome, Confirmation, Health Policy, Healthy, RFK Jr., Secretary, Senate, Skepticism, Transplant Registry Unified Management Program, Vaccines

RFK Jr., HHS Secretary, Senate confirmation, Trump administration, vaccine skepticism, healthcare policy, Make America Healthy Again

Biotech Industry Prepares for Trump 2.0: Regulatory Changes and M&A Activity Expected

4 months ago talkbio0Tagged biotech industry, Changing, Drug Industry, Health Policy, M&A activity, regulatory environment, Transplant Registry Unified Management Program, United States Food and Drug Administration

Biotech industry, Trump 2.0, FDA changes, M&A activity, regulatory environment, pharmaceutical industry, healthcare policy

Biopharma Industry Braces for Uncertainty Under Trump’s Second Term: Impact on Vaccines and M&A Deals

5 months ago talkbio0Tagged Biopharma Industry, Changing, FTC, Health Policy, M&A, Policy, Regulation, second, Trump 's, United States Federal Trade Commission, Vaccines

Trump’s second term, Biopharma industry, Vaccine regulation, Robert F. Kennedy Jr., M&A deals, FTC policy changes, Healthcare policy uncertainty

RFK Jr.’s HHS Nomination: A Potential Threat to the Biopharma Industry

5 months ago talkbio0Tagged Administration occupational activities, Biopharma, CHARGE Syndrome, Health Policy, Industry, nomination, RFK Jr., Skepticism, Transplant Registry Unified Management Program, Vaccines

RFK Jr., HHS nomination, biopharma industry, vaccine skepticism, health policies, Trump administration

Johnson & Johnson Abandons 340B Rebate Plan Following HRSA Pressure and Congressional Advocacy

7 months ago talkbio0Tagged Dosage Forms, drug discount program, Health Policy, HRSA, Johnson & Johnson, Study models

340B drug discount program, Johnson & Johnson, HRSA, rebate model, healthcare policy, pharmaceutical pricing

Medicare Drug Price Negotiation Program Upheld in Court, Defeating Boehringer Ingelheim’s Challenge

10 months ago talkbio0Tagged Boehringer, Drug Industry, Health Policy, Ingelheim, Legal, Medicare, Negotiation Program

Medicare, drug pricing, negotiation program, Boehringer Ingelheim, legal challenge, pharmaceutical industry, healthcare policy